Fig. 1 · Structure

Documents & Downloads

Efclarofusp alfa

Angiogenesis Inhibitor

Efclarofusp alfa is a humanized antibody engineered from CHO cells, comprising fused regions of VEGFR-1 and VEGFR-2 linked to a human IgG1 Fc domain. This reagent acts as an angiogenesis inhibitor, effectively disrupting neovascularization processes. It is utilized in research focused on vascular growth, tumor progression, and potential therapeutic strategies targeting angiogenic pathways.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 3053638-35-7
Applications Angiogenesis Inhibitor

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...